DMCC Speciality

  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: INE505A01010
  • NSEID: DMCC
  • BSEID: 506405
INR
261.70
-0.15 (-0.06%)
BSENSE

Dec 05

BSE+NSE Vol: 11.92 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

11.92 k (-52.67%) Volume

Shareholding (Sep 2025)

FII

0.39%

Held by 3 FIIs

DII

1.27%

Held by 1 DIIs

Promoter

53.84%

how big is DMCC Speciality?

06-Jun-2025

As of Jun 06, DMCC Speciality Chemicals Ltd has a market capitalization of 668.39 Cr, classifying it as a Micro Cap company, with recent net sales of 431.31 Cr and a net profit of 21.52 Cr over the last four quarters. The latest balance sheet shows shareholder's funds at 209.54 Cr and total assets of 364.72 Cr.

Market Cap: As of Jun 06, DMCC Speciality Chemicals Ltd has a market capitalization of 668.39 Cr, which classifies it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest 4 quarters, the sum of Net Sales is 431.31 Cr and the sum of Net Profit is 21.52 Cr. This data is presented on a Consolidated basis.<BR><BR>Balance Sheet Snapshot: This is also on a Consolidated basis for the latest annual period ending in Mar'24. The Shareholder's Funds are reported at 209.54 Cr, and the Total Assets amount to 364.72 Cr.

Read More

Who are in the management team of DMCC Speciality?

06-Jun-2025

As of March 2023, the management team of DMCC Speciality includes Laxmikumar N Goculdas (Chairman), Dilip Trimbak Gokhale (Whole-time Director), Bimal L Goculdas (Managing Director & CEO), and several independent directors, overseeing the company's operations and strategy.

As of March 2023, the management team of DMCC Speciality consists of the following individuals:<BR><BR>1. Laxmikumar N Goculdas - Chairman (Non-Executive)<BR>2. Dilip Trimbak Gokhale - Whole-time Director<BR>3. M T Ankleshwaria - Independent Director<BR>4. Mitika Laxmikumar Goculdas - Vice Chairperson<BR>5. Sanjeev Vishwanath Joshi - Independent Director<BR>6. Mukul Manoharlal Taly - Independent Director<BR>7. Bimal L Goculdas - Managing Director & CEO<BR>8. Janaki Ashwin Patwardhan - Independent Director<BR>9. Omkar Chandrakant Mhamunkar - Company Secretary & Compliance Officer<BR><BR>This team is responsible for overseeing the operations and strategic direction of the company.

Read More

What does DMCC Speciality do?

06-Jun-2025

DMCC Speciality Chemicals Ltd, established in 1919 and rebranded in 2022, operates in the specialty chemicals sector with a market cap of Rs 668 Cr, reporting net sales of 125 Cr and a net profit of 6 Cr for Q1 2025. Key metrics include a P/E ratio of 31.00 and a dividend yield of 0.37%.

Overview:<BR>DMCC Speciality Chemicals Ltd is a pioneer in the specialty chemicals industry and operates within the micro-cap market segment.<BR><BR>History:<BR>The company was incorporated in 1919 as 'Dharamsi Morarji Chemicals Company Limited' and changed its name to 'DMCC Speciality Chemicals Limited' on August 12, 2022. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 125 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: 6 Cr (Quarterly Results - Mar 2025)<BR>- Market-cap: Rs 668 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 31.00<BR>- Industry P/E: 47<BR>- Dividend Yield: 0.37%<BR>- Debt Equity: 0.18<BR>- Return on Equity: 9.46%<BR>- Price to Book: 2.96<BR><BR>Contact Details:<BR>Address: Prospect Chambers, 317/21 Dr D N Road Fort Mumbai Maharashtra : 400001<BR>Tel: 91-22-22048881/2/3<BR>Email: dgokhale@dmcc.com<BR>Website: http://www.dmcc.com

Read More

Has DMCC Speciality declared dividend?

06-Jun-2025

Yes, DMCC Speciality Chemicals Ltd has declared a 10% dividend, amounting to 1 per share, with an ex-date of August 28, 2024. While the company shows significant volatility in total returns over shorter periods, it has achieved a total return of 235.49% over the past five years.

DMCC Speciality Chemicals Ltd has declared a 10% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 10%<BR>- Amount per share: 1<BR>- Ex-date: 28 Aug 24<BR><BR>Dividend Yield: 0.37%.<BR><BR>Total Returns by Period:<BR>Over the last 6 months, the price return was -29.58%, with a dividend return of 0%, resulting in a total return of -29.58%.<BR><BR>In the past year, the price return was -13.21%, the dividend return was 0.31%, leading to a total return of -12.9%.<BR><BR>Over two years, the price return was 4.57%, with a dividend return of 0.37%, resulting in a total return of 4.94%.<BR><BR>For the three-year period, the price return was -26.25%, the dividend return was 0.62%, culminating in a total return of -25.63%.<BR><BR>In the four-year timeframe, the price return was -18.72%, with a dividend return of 0.77%, leading to a total return of -17.95%.<BR><BR>Finally, over five years, the price return was 230.67%, the dividend return was 4.82%, resulting in a total return of 235.49%.<BR><BR>Overall, while DMCC Speciality has declared a dividend, the total returns over various periods show significant volatility, with a notable decline in returns over shorter periods, contrasting with strong returns over the longer five-year horizon.

Read More

Who are the peers of the DMCC Speciality?

03-Jun-2025

DMCC Speciality's peers include Pidilite Inds., SRF, Gujarat Fluoroch, Deepak Nitrite, Himadri Special, Amal, Kronox Lab, Sunshield Chem., and Plastiblends (I). In terms of returns, DMCC Speciality has a 1-year return of -15.66%, lower than its peers, with Amal showing the highest return at 49.47%.

Peers: The peers of DMCC Speciality are Pidilite Inds., SRF, Gujarat Fluoroch, Deepak Nitrite, Himadri Special, Amal, Kronox Lab, Sunshield Chem., and Plastiblends (I).<BR><BR>Quality Snapshot: Excellent management risk is observed at Deepak Nitrite, while Good management risk is found at Pidilite Inds. and SRF. Average management risk is present at Gujarat Fluoroch, Himadri Special, DMCC Speciality, Amal, Kronox Lab, Sunshield Chem., and Black Rose Indus. Growth is classified as Good for Himadri Special and Amal, Average for Pidilite Inds. and SRF, and Below Average for Gujarat Fluoroch, Deepak Nitrite, DMCC Speciality, Kronox Lab, Sunshield Chem., Plastiblends (I), and Black Rose Indus. Capital Structure is Excellent for Pidilite Inds., SRF, Deepak Nitrite, and Plastiblends (I), Good for Gujarat Fluoroch, Himadri Special, and DMCC Speciality, Average for Amal, and Below Average for Sunshield Chem.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Amal at 49.47%, while the lowest is Deepak Nitrite at -9.64%. DMCC Speciality's 1-year return is -15.66%, which is lower than both. Additionally, the six-month return is negative for Deepak Nitrite, Himadri Special, DMCC Speciality, Kronox Lab, Sunshield Chem., and Black Rose Indus.

Read More

Who are the top shareholders of the DMCC Speciality?

17-Jul-2025

The top shareholder of DMCC Speciality is Laxmikumar Narottam Goculdas, holding 36.27%, followed by individual investors with 33.75%. Other notable shareholders include Girish Gulati (HUF) at 2.28%, with minimal holdings from mutual funds (0.01%) and foreign institutional investors (1.16%).

The top shareholders of DMCC Speciality include Laxmikumar Narottam Goculdas, who holds the largest share at 36.27%. The company is primarily owned by promoters, with no pledged promoter holdings reported. Additionally, there are individual investors who collectively hold 33.75% of the shares. The highest public shareholder is Girish Gulati (HUF), with a holding of 2.28%. The company also has a small percentage of shares held by mutual funds (0.01%) and foreign institutional investors (1.16%) across six different entities.

Read More

When is the next results date for DMCC Speciality?

04-Nov-2025

The next results date for DMCC Speciality is 11 November 2025.

The next results date for DMCC Speciality is scheduled for 11 November 2025.

Read More

Are DMCC Speciality latest results good or bad?

12-Nov-2025

DMCC Speciality Chemicals reported a 22.68% increase in sales to ₹126.03 crores, indicating market share growth; however, declining operating margins and net profit raise concerns about profitability and operational efficiency. Overall, the results are mixed and suggest the need for management to address these challenges.

The latest results for DMCC Speciality Chemicals indicate a mixed performance, with some concerning trends. On the positive side, the company achieved a 22.68% year-on-year increase in sales, reaching ₹126.03 crores. This demonstrates its ability to capture market share in the specialty chemicals sector.<BR><BR>However, the financial health of the company shows significant challenges. Operating margins have compressed to 11.12%, the lowest in recent quarters, which indicates deteriorating operational efficiency. This margin compression is a critical concern, as it suggests that rising input costs and operational inefficiencies are impacting profitability despite the revenue growth. <BR><BR>Net profit for the quarter was ₹5.75 crores, reflecting a decline of 1.03% year-on-year and a more significant drop of 25.90% compared to the previous quarter. The PAT margin also decreased to 4.56%, down from 5.66% a year earlier. <BR><BR>In summary, while DMCC has demonstrated revenue growth, the accompanying decline in margins and profitability raises red flags about its operational effectiveness and ability to sustain earnings growth. Overall, the results can be viewed as concerning, highlighting the need for management to address these operational challenges to improve financial performance moving forward.

Read More

Is DMCC Speciality overvalued or undervalued?

20-Nov-2025

As of November 19, 2025, DMCC Speciality is considered very attractive and undervalued compared to peers in the specialty chemicals sector, with favorable key ratios indicating strong growth potential despite a recent year-to-date return of -27.89%.

As of 19 November 2025, the valuation grade for DMCC Speciality has moved from attractive to very attractive, indicating a significant improvement in its perceived value. The company is currently considered undervalued, especially when compared to its peers in the specialty chemicals sector. Key ratios include a PE ratio of 23.89, an EV to EBITDA of 11.02, and a PEG ratio of 0.22, which suggests strong growth potential relative to its price.<BR><BR>In comparison with peers, DMCC Speciality's valuation stands out favorably against companies like Solar Industries, which has a PE ratio of 94.38, and Gujarat Fluoroch, with a PE ratio of 56.8, both categorized as very expensive. This stark contrast highlights DMCC's relative attractiveness in the market. Despite recent underperformance with a year-to-date return of -27.89% compared to the Sensex's 9.02%, the fundamental metrics suggest that DMCC Speciality is positioned well for future growth and recovery.

Read More

Should I buy, sell or hold DMCC Speciality?

04-Dec-2025

How has been the historical performance of DMCC Speciality?

04-Dec-2025

DMCC Speciality's historical performance shows significant growth in net sales and profitability, with net sales rising from INR 327.95 crore in March 2024 to INR 431.30 crore in March 2025, and profit after tax increasing to INR 21.53 crore. However, rising raw material costs impacted overall expenditure, while total assets and liabilities remained stable.

Answer:<BR>The historical performance of DMCC Speciality shows a mixed trend across various financial metrics over the years.<BR><BR>Breakdown:<BR>DMCC Speciality's net sales increased significantly from INR 327.95 crore in March 2024 to INR 431.30 crore in March 2025, following a dip to INR 386.65 crore in March 2023. The total operating income mirrored this trend, reaching INR 431.30 crore in March 2025. However, raw material costs also rose to INR 259.09 crore in March 2025, up from INR 195.51 crore in March 2024, contributing to a total expenditure of INR 374.28 crore. This resulted in an operating profit (PBDIT) of INR 58.36 crore for March 2025, an increase from INR 46.71 crore in the previous year. Profit before tax also improved to INR 31.14 crore in March 2025, compared to INR 17.25 crore in March 2024, leading to a profit after tax of INR 21.53 crore. The company's earnings per share rose to INR 8.63 in March 2025 from INR 4.65 in March 2024. On the balance sheet, total assets increased to INR 371.92 crore in March 2025, while total liabilities were INR 371.92 crore, indicating a stable financial position. Cash flow from operating activities remained steady at INR 38 crore in March 2025, with a net cash inflow of INR 1 crore. Overall, DMCC Speciality demonstrated growth in sales and profitability, despite rising costs and fluctuating cash flows.

Read More

Why is DMCC Speciality falling/rising?

04-Dec-2025

As of 04-Dec, DMCC Speciality Chemicals Ltd's stock price is at Rs 261.90, down 4.12% after three days of gains. The stock has significantly underperformed the sector and the benchmark Sensex, with a year-to-date decline of 29.22%.

As of 04-Dec, DMCC Speciality Chemicals Ltd's stock price is falling, currently at Rs 261.90, which reflects a decrease of Rs 11.25 or 4.12%. This decline follows a trend reversal after three consecutive days of gains. The stock has underperformed its sector by 3.91% today and has experienced a significant drop of 13.19% over the past month, while the benchmark Sensex has gained 2.16% during the same period. <BR><BR>Additionally, the stock's year-to-date performance shows a decline of 29.22%, contrasting sharply with the Sensex's increase of 9.12%. Over the past year, DMCC has fallen by 33.19%, while the Sensex has risen by 5.32%. The stock also touched an intraday low of Rs 260, indicating a 4.81% drop at its lowest point today. <BR><BR>Despite a rise in investor participation, with delivery volume increasing by 105.94% against the 5-day average, the stock remains below its longer-term moving averages, which suggests a bearish trend. Overall, these factors contribute to the current decline in DMCC Speciality Chemicals Ltd's stock price.

Read More

Is DMCC Speciality technically bullish or bearish?

05-Dec-2025

As of December 4, 2025, DMCC Speciality is in a bearish trend with strong indications of weakness, supported by bearish MACD readings, moving averages, and KST across multiple time frames.

As of 4 December 2025, the technical trend has changed from mildly bearish to bearish. The current stance is bearish with a strong indication of weakness. The weekly and monthly MACD readings are both bearish, reinforcing the negative outlook. The daily moving averages also confirm a bearish trend. Additionally, the KST is bearish on both weekly and monthly time frames, while the Bollinger Bands and OBV show mildly bearish conditions on the weekly. Overall, the combination of these indicators suggests a significant bearish sentiment for DMCC Speciality.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor long term growth as Operating profit has grown by an annual rate 18.91% of over the last 5 years

 
2

Falling Participation by Institutional Investors

3

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

INR 655 Cr (Micro Cap)

stock-summary
P/E

23.00

stock-summary
Industry P/E

40

stock-summary
Dividend Yield

0.95%

stock-summary
Debt Equity

0.16

stock-summary
Return on Equity

11.89%

stock-summary
Price to Book

2.79

Revenue and Profits:
Net Sales:
126 Cr
(Quarterly Results - Sep 2025)
Net Profit:
6 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.95%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-14.76%
0%
-14.76%
6 Months
-3.13%
0.92%
-2.21%
1 Year
-29.39%
0.68%
-28.71%
2 Years
-13.97%
1.15%
-12.82%
3 Years
-12.25%
1.27%
-10.98%
4 Years
-16.5%
1.47%
-15.03%
5 Years
71.33%
2.91%
74.24%

Latest dividend: 2.5 per share ex-dividend date: Aug-22-2025

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News

Is DMCC Speciality technically bullish or bearish?

Overview of Current Technical Landscape

The technical trend for DMCC Speciality shifted from mildly bearish to outright bearish as of 04 Dec 2025, reflecting a deterioration in market sentiment. This shift is corroborated by multiple technical tools across different timeframes, suggesting a consistent downtrend rather than isolated short-term fluctuations.

Key momentum indicators such as the Moving Average Convergence Divergence (MACD) are bearish on both weekly and monthly charts, indicating sustained selling pressure. Similarly, the Know Sure Thing (KST) oscillator aligns with this bearish outlook on weekly and monthly timeframes, reinforcing the negative momentum.

Moving averages on the daily chart also confirm a bearish stance, with the current price trading...

Read More
Announcements stock-summary

Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

03-Dec-2025 | Source : BSE

As per attachment.

Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

01-Dec-2025 | Source : BSE

As per attachment

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

17-Nov-2025 | Source : BSE

As per attachment.

Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

DMCC Speciality Chemicals Ltd has declared 25% dividend, ex-date: 22 Aug 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
23.05%
EBIT Growth (5y)
18.91%
EBIT to Interest (avg)
4.90
Debt to EBITDA (avg)
1.58
Net Debt to Equity (avg)
0.16
Sales to Capital Employed (avg)
1.31
Tax Ratio
30.36%
Dividend Payout Ratio
28.96%
Pledged Shares
0
Institutional Holding
1.67%
ROCE (avg)
11.07%
ROE (avg)
8.81%
Valuation key factors
Factor
Value
P/E Ratio
23
Industry P/E
40
Price to Book Value
2.79
EV to EBIT
14.63
EV to EBITDA
10.82
EV to Capital Employed
2.54
EV to Sales
1.39
PEG Ratio
0.21
Dividend Yield
0.96%
ROCE (Latest)
17.39%
ROE (Latest)
11.89%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 2 Schemes (0.01%)

FIIs

Held by 3 FIIs (0.39%)

Promoter with highest holding

Laxmikumar Narottam Goculdas (36.27%)

Highest Public shareholder

Girish Gulati (huf) . (2.28%)

Individual Investors Holdings

34.51%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 22.68% vs 34.25% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is -1.03% vs 145.15% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "126.03",
          "val2": "102.73",
          "chgp": "22.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "14.01",
          "val2": "15.32",
          "chgp": "-8.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.91",
          "val2": "2.77",
          "chgp": "-31.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "5.75",
          "val2": "5.81",
          "chgp": "-1.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.12%",
          "val2": "14.91%",
          "chgp": "-3.79%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 34.58% vs 16.00% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 88.16% vs 30.31% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "253.07",
          "val2": "188.04",
          "chgp": "34.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "30.87",
          "val2": "24.16",
          "chgp": "27.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.93",
          "val2": "5.78",
          "chgp": "-32.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "13.51",
          "val2": "7.18",
          "chgp": "88.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.20%",
          "val2": "12.85%",
          "chgp": "-0.65%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 26.15% vs -16.37% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 158.59% vs 2,325.00% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "306.08",
          "val2": "242.64",
          "chgp": "26.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "41.89",
          "val2": "27.52",
          "chgp": "52.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "8.31",
          "val2": "9.91",
          "chgp": "-16.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "15.05",
          "val2": "5.82",
          "chgp": "158.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.69%",
          "val2": "11.34%",
          "chgp": "2.35%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 31.51% vs -15.18% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 85.76% vs 67.24% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "431.30",
          "val2": "327.95",
          "chgp": "31.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "57.02",
          "val2": "36.27",
          "chgp": "57.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "10.50",
          "val2": "13.76",
          "chgp": "-23.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "21.53",
          "val2": "11.59",
          "chgp": "85.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.22%",
          "val2": "11.06%",
          "chgp": "2.16%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Sep'25 - YoYstock-summary
Sep'25
Sep'24
Change(%)
Net Sales
126.03
102.73
22.68%
Operating Profit (PBDIT) excl Other Income
14.01
15.32
-8.55%
Interest
1.91
2.77
-31.05%
Exceptional Items
0.00
0.00
Consolidate Net Profit
5.75
5.81
-1.03%
Operating Profit Margin (Excl OI)
11.12%
14.91%
-3.79%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in quarter ended Sep 2025 is 22.68% vs 34.25% in Sep 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is -1.03% vs 145.15% in Sep 2024

Half Yearly Results Snapshot (Consolidated) - Sep'25stock-summary
Sep'25
Sep'24
Change(%)
Net Sales
253.07
188.04
34.58%
Operating Profit (PBDIT) excl Other Income
30.87
24.16
27.77%
Interest
3.93
5.78
-32.01%
Exceptional Items
0.00
0.00
Consolidate Net Profit
13.51
7.18
88.16%
Operating Profit Margin (Excl OI)
12.20%
12.85%
-0.65%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 34.58% vs 16.00% in Sep 2024

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2025 is 88.16% vs 30.31% in Sep 2024

Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
306.08
242.64
26.15%
Operating Profit (PBDIT) excl Other Income
41.89
27.52
52.22%
Interest
8.31
9.91
-16.15%
Exceptional Items
0.00
0.00
Consolidate Net Profit
15.05
5.82
158.59%
Operating Profit Margin (Excl OI)
13.69%
11.34%
2.35%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 26.15% vs -16.37% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 158.59% vs 2,325.00% in Dec 2023

Annual Results Snapshot (Consolidated) - Mar'25stock-summary
Mar'25
Mar'24
Change(%)
Net Sales
431.30
327.95
31.51%
Operating Profit (PBDIT) excl Other Income
57.02
36.27
57.21%
Interest
10.50
13.76
-23.69%
Exceptional Items
0.00
0.00
Consolidate Net Profit
21.53
11.59
85.76%
Operating Profit Margin (Excl OI)
13.22%
11.06%
2.16%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 31.51% vs -15.18% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 85.76% vs 67.24% in Mar 2024

stock-summaryCompany CV
About DMCC Speciality Chemicals Ltd stock-summary
stock-summary
DMCC Speciality Chemicals Ltd
Micro Cap
Specialty Chemicals
DMCC Speciality Chemicals Limited was erstwhile incorporated as 'Dharamsi Morarji Chemicals Company Limited' on September 25, 1919. The Company changed the name from 'Dharamsi Morarji Chemicals Company Limited' to 'DMCC Speciality Chemicals Limited' on August 12, 2022. Promoted by the Late Ratansi D Morarji to manufacture chemicals at Ambernath, Company is a pioneer in the Indian chemical industry.
Company Coordinates stock-summary
Company Details
Prospect Chambers, 317/21 Dr D N Road Fort Mumbai Maharashtra : 400001
stock-summary
Tel: 91-22-22048881/2/3
stock-summary
dgokhale@dmcc.com
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai